Paper29367232
High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.
He Y and 2 others. Arterioscler Thromb Vasc Biol, 2018. Cited by 45 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus. Papers, record 29367232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367232
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Cholesterol, HDL | Major topic |
| Diabetes Mellitus | Major topic |
| Animals | |
| Biomarkers | |
| Endothelial Cells | |
| Epigenesis, Genetic | |
| Humans | |
| MicroRNAs | |
| Prognosis | |
| Risk Factors | |
| Transcription Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DP3 DK108209 | NIDDK NIH HHS | United States | DP3DK108209 | PubMed and NIH | NIH RePORTER |
| P01 HL092969 | NHLBI NIH HHS | United States | P01HL092969 | PubMed and NIH | NIH RePORTER |
| P01 HL128203 | NHLBI NIH HHS | United States | P01HL128203 | PubMed and NIH | NIH RePORTER |
| P30 DK017047 | NIDDK NIH HHS | United States | P30DK017047 | PubMed and NIH | NIH RePORTER |
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,784,702 | Functionality of High-Density Lipoprotein as Antiatherosclerotic Therapeutic Target. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/27784702 | PubMed |
| 2 | 28,882,868 | Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28882868 | PubMed |
| 3 | 17,387,129 | Effect of torcetrapib on the progression of coronary atherosclerosis. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17387129 | PubMed |
| 4 | 26,543,096 | Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/26543096 | PubMed |
| 5 | 2,677,733 | High-density lipoprotein--the clinical implications of recent studies. | N Engl J Med | 1989 | https://conductscience.org/library/papers/2677733 | PubMed |
| 6 | 26,564,598 | Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. | J Am Coll Cardiol | 2015 | https://conductscience.org/library/papers/26564598 | PubMed |
| 7 | 24,951,757 | MicroRNA-management of lipoprotein homeostasis. | Circ Res | 2014 | https://conductscience.org/library/papers/24951757 | PubMed |
| 8 | 17,110,242 | Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. | Clin Lab Med | 2006 | https://conductscience.org/library/papers/17110242 | PubMed |
| 9 | 22,085,343 | Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22085343 | PubMed |
| 10 | 22,796,256 | High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). | J Am Coll Cardiol | 2012 | https://conductscience.org/library/papers/22796256 | PubMed |
| 11 | 21,537,175 | Metabolic and functional relevance of HDL subspecies. | Curr Opin Lipidol | 2011 | https://conductscience.org/library/papers/21537175 | PubMed |
| 12 | 197,124 | High density lipoprotein metabolism in man. | J Clin Invest | 1977 | https://conductscience.org/library/papers/197124 | PubMed |
| 13 | 29,025,709 | Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/29025709 | PubMed |
| 14 | 20,466,885 | MiR-33 contributes to the regulation of cholesterol homeostasis. | Science | 2010 | https://conductscience.org/library/papers/20466885 | PubMed |
| 15 | 28,860,221 | Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28860221 | PubMed |
| 16 | 28,360,088 | VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28360088 | PubMed |
| 17 | 19,797,709 | Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. | Arterioscler Thromb Vasc Biol | 2010 | https://conductscience.org/library/papers/19797709 | PubMed |
| 18 | 27,765,770 | Pim-1L Protects Cell Surface-Resident ABCA1 From Lysosomal Degradation in Hepatocytes and Thereby Regulates Plasma High-Density Lipoprotein Level. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/27765770 | PubMed |
| 19 | 28,450,350 | Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). | Circulation | 2017 | https://conductscience.org/library/papers/28450350 | PubMed |
| 20 | 20,798,376 | ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. | Arterioscler Thromb Vasc Biol | 2010 | https://conductscience.org/library/papers/20798376 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,888,332 | Apolipoprotein A1 attenuates epirubicin-induced cardiotoxicity with GPX4-linked ferroptosis-defense modulation. | Apoptosis | 2026 | https://conductscience.org/library/papers/42888332 | PubMed |
| 42,339,086 | Study on the construction of a risk assessment model for type 2 diabetes complications based on GlycA and HDL1-TC. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42339086 | PubMed |
| 42,277,343 | Dose‑dependent association of smoking exposure with HDL subfraction cholesterol content. | Sci Rep | 2026 | https://conductscience.org/library/papers/42277343 | PubMed |
| 42,163,957 | Chinese visceral adiposity index outperforms insulin resistance indices in predicting cardiovascular disease risk: a 12-year prospective cohort study. | Front Nutr | 2026 | https://conductscience.org/library/papers/42163957 | PubMed |
| 41,410,853 | Inventive HDL Mimicking Nanoparticles: A Promising Frontier in Cardiovascular Disease Management. | Cardiovasc Toxicol | 2025 | https://conductscience.org/library/papers/41410853 | PubMed |
| 41,304,981 | Is Crocin Effective in Modulating Blood Lipid Levels? An Updated Systematic Review and Meta-Analysis with Dose- and Time-Response Assessments. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304981 | PubMed |
| 40,840,700 | Multiple facets of HDLs as modifiable risk factors in stroke-the good, the bad, and the ugly. | J Lipid Res | 2025 | https://conductscience.org/library/papers/40840700 | PubMed |
| 40,696,331 | Association between hs-CRP/HDL-C ratio and risk of prediabetes or diabetes: a cross-sectional study based on NHANES 2015-2023. | BMC Endocr Disord | 2025 | https://conductscience.org/library/papers/40696331 | PubMed |
| 40,078,176 | Neutrophil-related immune-inflammatory biomarkers influence the early progression of medial medullary infarction. | Front Neurol | 2025 | https://conductscience.org/library/papers/40078176 | PubMed |
| 36,878,958 | Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese. | Sci Rep | 2023 | https://conductscience.org/library/papers/36878958 | PubMed |
| 36,670,930 | Gestational Hypertension and High-Density Lipoprotein Function: An Explorative Study in Overweight/Obese Women of the DALI Cohort. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36670930 | PubMed |
| 35,682,748 | Effects of Individual Amino Acids on PPARα Transactivation, mTORC1 Activation, ApoA-I Transcription and pro-ApoA-I Secretion. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682748 | PubMed |
| 35,389,891 | Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease. | JCI Insight | 2022 | https://conductscience.org/library/papers/35389891 | PubMed |
| 35,237,989 | Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35237989 | PubMed |
| 35,237,971 | Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35237971 | PubMed |
| 34,946,565 | Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein. | Molecules | 2021 | https://conductscience.org/library/papers/34946565 | PubMed |
| 34,262,524 | Monocyte to High-Density Lipoprotein Ratio Is Associated With Early Neurological Deterioration in Acute Isolated Pontine Infarction. | Front Neurol | 2021 | https://conductscience.org/library/papers/34262524 | PubMed |
| 34,075,063 | High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome. | Sci Rep | 2021 | https://conductscience.org/library/papers/34075063 | PubMed |
| 33,980,518 | Association between extremely high high-density lipoprotein-cholesterol and hypertensive retinopathy: results of a cross-sectional study from Kanagawa Investigation of Total Checkup Data from the National Database-6 (KITCHEN-6). | BMJ Open | 2021 | https://conductscience.org/library/papers/33980518 | PubMed |
| 33,923,393 | Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity. | J Clin Med | 2021 | https://conductscience.org/library/papers/33923393 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29367232
GET https://conductscience.org/api/papers/v1/29367232/references?page=2